14 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro]
RxNorm concept 2729307, branded drug (sbd). Prescribable name: Rybrevant Faspro 2240 MG / 28000 UNT in 14 ML Injection.
- RxCUI
- 2729307
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2729307 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Rybrevant Faspro (amivantamab-lpuj 2240 MG / hyaluronidase-lpuj 28000 UNT) per 14 ML Injection; Rybrevant Faspro 2240 MG / 28000 UNT per 14 ML Injection
Related concepts
- amivantamab-lpuj 160 MG/ML (SCDC, consists of)
- hyaluronidase-lpuj 2000 UNT/ML (SCDC, consists of)
- amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML [Rybrevant Faspro] (SBDC, consists of)
- Injection (DF, has dose form)
- Rybrevant Faspro (BN, has ingredient)
- 14 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2729307 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2729307 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2729307. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.